Low

I’m Worried Masters of the Universe Is Repeating This $208M Fantasy Franchise Reboot Bomb

Variety reports that the 2026 “Masters of the Universe” reboot is targeting a $30–35 million opening weekend, relying on strong word of mouth. The article compares its outlook with 2023’s “Dungeons & Dragons: Honor Among Thieves,” which opened with $37 million and earned a $208 million lifetime gross against a $150 million budget. It notes “Masters of the Universe” cost over $170 million.

1/10
2/10
Low
this weekend box-office outlook
risk-off for high-budget legacy fantasy reboots

Background

The article argues the 2026 Masters of the Universe reboot may repeat the box-office outcome of 2023 Dungeons & Dragons: Honor Among Thieves, citing opening-weekend expectations and prior lifetime gross vs budget.

Why it matters

It’s an opinionated box-office outlook piece using comparative performance (including a $208M lifetime gross vs a $150M price tag for D&D) to infer sequel risk and broader implications for ‘80s fantasy live-action reboots.

Market relevance

No specific publicly traded studio/rights holder is identified as the subject; the piece is primarily a theatrical performance narrative and read-across risk discussion.

Market effects

Highlights risk of high-budget legacy fantasy reboots underperforming when viral/genre films dominate.

US box-office framing (opening weekend take) suggests near-term sentiment pressure on theatrical slate expectations.

If read-across holds, could pressure global theatrical performance assumptions for similar IP reboots.

Alternative perspectives

Strong word-of-mouth can still swing opening-weekend expectations; early projections may not reflect final legs.

Marketing spend, release-date competition, and international box-office mix could materially change the profitability outlook versus the article’s framing.

Key entities

  • Masters of the Universe (film)

    2026 reboot discussed as facing a tough opening weekend and potential underperformance.

  • Dungeons & Dragons: Honor Among Thieves (film)

    2023 reboot used as the main comparison for potential sequel-unlikelihood after underwhelming economics.

  • Obsession (film)

    Cited as outperforming expectations and drawing viral attention, raising competitive pressure.

  • Backrooms (film)

    Cited as having a strong US opening weekend ($81M) and viral popularity.

Related articles

$PRUMed

Argus Moves Prudential Financial (PRU) to Hold, Awaiting Clarity on Japan Operations

Argus downgraded Prudential Financial (PRU) to Hold from Buy on June 9, citing ongoing challenges in Japan. Prudential said it will extend the suspension of new Japan sales by 180 days after a prior 90-day pause. Argus noted long-term above-average ROE and a ~5.4% dividend yield, and said it could upgrade with more clarity. In Q1 2026, PRU reported retail annuity sales over $3B, $1.4B in PRT deals, and after-tax adjusted operating income of ~$1.3B ($3.61/share).

$RNTXMedAI 8/10

Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom

Rein Therapeutics (NASDAQ: RNTX) said it has expanded its Phase 2 RENEW trial of inhaled peptide LTI-03 for idiopathic pulmonary fibrosis into the United Kingdom, with the first U.K. patient randomized. The company reported 16 patients enrolled to date. Trial sites are enrolling in the U.S., Australia, and the U.K., with two additional countries expected to add sites soon.

$ACNLow

Accenture (ACN) Faces Lower Price Target from TD Cowen as Industry Challenges Persist

TD Cowen cut its Accenture (ACN) price target to $258 from $282 and kept a Buy rating, citing ongoing pressure on the company and the services sector from AI-related changes and macroeconomic challenges. It said fiscal Q3 results are unlikely to shift cautious sentiment. Separately, JPMorgan lowered its target to $201 from $247, maintaining Overweight and adjusting estimates to match Accenture’s guidance midpoint.

$CILow

Mizuho Sees Improved Regulatory Stability, Raises Cigna (CI) Price Objective

Mizuho raised its Cigna (CI) price objective to $340 from $330 and reiterated an Outperform rating, citing a more stable, predictable managed-care policy environment and fewer severe policy surprises. Mizuho also lifted price targets across the sector. UBS increased its CI target to $400 from $375, maintaining Buy, citing stronger Q1 results and improved Medicare Advantage and ACA trends, while noting ongoing cost pressures.

$UPSLow

UPS meets deadline for retrofitting delivery vans with air conditioning

UPS met its June 1 deadline to retrofit 2,000 parcel delivery vans in the hottest U.S. regions with air conditioning, Teamsters General President Sean O’Brien said. The union also cited a pilot piping cooled air into rear cargo areas. UPS previously agreed in October to modify 5,000 vehicles by June 1, 2027, and to upgrade 100 cars with vented cargo-compartment cooling.

$AMZNMedAI 8/10

Amazon's Record C$14 Billion Bond Sale Pressures Canadian Credit Market

Amazon priced a record C$14 billion bond sale in Canada (about $10 billion), including a C$4.75 billion 30-year tranche. The deal is the largest corporate bond in Canadian dollars, surpassing Alphabet’s C$8.5 billion issue, and moved Amazon into the top 10 issuers by outstanding debt in a Bloomberg index. Canadian bond investors reportedly sold some longer-dated issues to make room; spreads widened ~2 bps Tuesday.